Clinical trial NCT06345924: Music Therapy for Cancer Patients(Meraki_PC)
Official title: Meraki: Music Therapy Protocol for People with Palliative Care
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Cancer
Palliative Care
Keywords: cancer
psychological intervention
palliative care
music therapy-based treatment
Lead sponsor: University of Valencia
Sponsor class: OTHER
First posted: 2024-04-03
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The overall aim of the study is to analyse the impact of a music therapy-based treatment on the emotional well-being and quality of life of cancer patients in palliative care (PC). To this end, the effectiveness and efficiency of a music therapy-based treatment to improve adaptation to illness and psychological well-being in this population will be validated and implemented.

Specifically, the implementation of an individualised treatment programme for palliative care patients will be carried out.


Eligibility criteria: Inclusion Criteria:

* The patient is receiving palliative care for an oncological diagnosis and was admitted to the hospital a week ago. They do not have moderate to severe cognitive impairment. This treatment is for oncological patients in an advanced stage who are receiving palliative anti-tumour treatment such as chemotherapy and/or radiotherapy. These patients require support treatment that cannot be provided at home due to their complexity. The patient is in an advanced or terminal phase of the disease according to WHO criteria.
* Be over 18 years of age.
* Have preserved cognitive ability (SPMSQ, Pfeiffer). More than 2 errors (3 in illiterate persons) would suggest the presence of cognitive impairment.
* Have signed the informed consent form
* Have completed at least 2 of the 3 treatment sessions and have completed the pre-test and post-test assessment.

Exclusion Criteria:

-Estimated survival time. Patients with a life expectancy of two weeks or less shall not be operated on.

Primary outcomes:
measure: Change in Anxiety and Depression Symptomatology (T1, T2 and T4)
timeFrame: Baseline up to 1 month
measure: Change in Quality of Life (T1, T2 and T4)
timeFrame: Baseline up to 1 month
measure: Change in emotional distress (T1, T2, T3 and T4)
timeFrame: Baseline up to 1 month
Secondary outcomes:
measure: Change in Social Suport (T1 and T4)
timeFrame: Baseline up to 1 month
measure: Change in Resilience (T1 and T4)
timeFrame: Baseline up to 1 month
measure: Change in Spirituality (T1 and T4)
timeFrame: Baseline up to 1 month
measure: Change Knowledge of the disease (T1 and T4)
timeFrame: Baseline up to 1 month
measure: Barthel Index
timeFrame: Baseline
measure: Pfeiffer Short Form Mental State Questionnaire, SPMSQ
timeFrame: Baseline
measure: Charlson Comorbidity Index (CCI)
timeFrame: Baseline
Other outcomes:
Locations:
city: Serra
country: Spain
facility: Hospital Dr. Moliner
state: Valencia
Study officials:
affiliation: University of Valencia
name: Marián Pérez Marín, PhD
role: PRINCIPAL_INVESTIGATOR
References: